23andMe files for bankruptcy in U.S., putting DNA data of 15 million customers up for sale

The U.S. bankruptcy filing of 23andMe, one of the biggest direct-to-consumer genetic testers in the world, is raising concerns about what will happen to the personal health information of millions of users if the company is sold.The San Francisco-based company was credited by Time magazine with the best invention of 2008 for its saliva-based, at-home DNA test that would report a customer’s ancestry, promising results down to a tenth of a percentage point. It later added health services that would use the genetic results to make drug recommendations or offer guidance on causes of migraines, for example.